Editorial and Update Policy — How We Source and Correct

What we publish

We cover one narrow thing: assets that are hard or impossible to access through a normal broker, and the mechanics of reaching them. That includes private companies with no public listing, commodities that retail platforms do not carry, and the instruments used to get exposure to them.

We do not publish price predictions, trading signals, or “top picks.” We earn money from referral commissions, which makes us the wrong source for an opinion on where a price is going.

How we source data

Contract data — prices, funding rates, open interest, leverage limits — comes from the public Hyperliquid API and is refreshed when the site is built. The retrieval date appears next to the data. You can query the same public endpoint and verify any number on this site.

Everything else — access rules, fee structures, regulatory status — is sourced from primary documents where they exist. When we cannot verify something, we say so rather than filling the gap.

How often pages are updated

We separate three kinds of freshness, because conflating them produces pages that look updated but are not:

Market data refreshes on every build. This does not change a page’s stated update date, because nothing about the analysis changed.

Analysis and rules are reviewed quarterly, and rewritten whenever the underlying facts change — a new fee tier, a change in country availability, a new access route.

Events trigger immediate updates: a new listing, a rule change, or material news about a covered asset.

Each page carries a change record listing what actually changed and when. We do not bump dates without a substantive edit.

Corrections

If a page is wrong, tell us and we will fix it and note the correction in that page’s change record. We would rather be corrected than be trusted by default.

Risk

Nothing on this site is financial advice. Perpetual futures are leveraged instruments and most retail accounts trading them lose money. A perpetual contract on a private company’s valuation gives you no shares, no shareholder rights, and no allocation in any future IPO.